Teleflex (TFX) Set to Announce Earnings on Thursday

Teleflex (NYSE:TFX) will be posting its quarterly earnings results before the market opens on Thursday, October 31st. Analysts expect Teleflex to post earnings of $3.38 per share for the quarter. Teleflex has set its FY24 guidance at $13.80-14.20 EPS and its FY 2024 guidance at 13.800-14.200 EPS.Individual that are interested in registering for the company’s earnings conference call can do so using this link.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, August 1st. The medical technology company reported $3.42 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.33 by $0.09. The firm had revenue of $749.70 million during the quarter, compared to the consensus estimate of $762.98 million. Teleflex had a return on equity of 14.51% and a net margin of 8.76%. The business’s revenue for the quarter was up .9% on a year-over-year basis. During the same quarter in the prior year, the company earned $3.41 EPS. On average, analysts expect Teleflex to post $14 EPS for the current fiscal year and $15 EPS for the next fiscal year.

Teleflex Trading Down 0.1 %

NYSE TFX opened at $236.44 on Wednesday. The business’s fifty day moving average is $240.99 and its 200-day moving average is $224.01. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.58 and a quick ratio of 1.44. The stock has a market capitalization of $11.14 billion, a price-to-earnings ratio of 42.45, a PEG ratio of 2.12 and a beta of 1.16. Teleflex has a one year low of $177.63 and a one year high of $257.85.

Teleflex Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, September 16th. Shareholders of record on Thursday, August 15th were given a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 0.58%. The ex-dividend date was Thursday, August 15th. Teleflex’s dividend payout ratio is 24.42%.

Insider Buying and Selling at Teleflex

In other news, Director Stuart A. Randle sold 2,674 shares of the firm’s stock in a transaction on Friday, August 16th. The stock was sold at an average price of $238.93, for a total value of $638,898.82. Following the completion of the transaction, the director now directly owns 5,496 shares of the company’s stock, valued at $1,313,159.28. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 1.43% of the company’s stock.

Analyst Upgrades and Downgrades

TFX has been the subject of a number of research reports. Royal Bank of Canada increased their target price on shares of Teleflex from $260.00 to $275.00 and gave the company an “outperform” rating in a research report on Tuesday, October 8th. Truist Financial raised their target price on Teleflex from $247.00 to $255.00 and gave the stock a “hold” rating in a research report on Monday, October 14th. Finally, Stephens boosted their target price on Teleflex from $275.00 to $290.00 and gave the company an “overweight” rating in a research note on Friday, August 2nd. Three research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $268.86.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.